MDA’s H1N1 Resource Center

It’s no secret that more than one kind of flu virus will be spreading through our communities in the coming months, including seasonal influenza and the 2009 H1N1 flu. Because individuals affected by neuromuscular disease are at increased risk of serious and possibly devastating complications from H1N1, it’s important that everyone stays informed and takes steps to protect ourselves and our families.

An H1N1 vaccine has been developed.  Priority is being given to target groups deemed to be at increased risk for serious medical complications from the H1N1 virus, including the following:

  • Pregnant women
  • Household contacts and caregivers for children younger than 6 months of age
  • Healthcare and emergency medical services personnel
  • All people from 6 months through 24 years of age
  • Persons aged 25 through 64 years who have health conditions associated with higher risk of medical complications from influenza.

There is an intranasal form (sprayed into the nose) of the vaccine available. However, it's important to know that this variety of the vaccine is not recommended for those affected by neuromuscular disease since it contains an attenuated (weakened) form of the H1N1 virus.

An injectable form of the vaccine is available. In addition to receiving this form of the vaccine, there’s a lot we can do to prepare for and help protect everyone from the flu, which is why we’ve gathered information, recommended guidelines and credible resources to keep you informed. Updates will be posted as new information becomes available.